Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
lin Lin, doctor
CONTACT
lin Wang, doctor
CONTACT
Lead
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
In this study, eligible subject will be Subjects will have the opportunity to receive the treatment of Camrelizumab in combination with pemetrexed and carboplatin therapy .
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted